Fran Hawthorne How to Profit from Faster FDA and Better Science Buoyed by advances in genomics and a speedier FDA, health care investors are seeking moneymaking opportunities among pharmaceuticals companies developing expensive, new drugs. Fran Hawthorne August 1, 2012